No Data
No Data
Arcadia Biosciences, Inc. Announces Q1 2025 Financial Results Release and Conference Call Schedule
Arcadia's Physical Therapy Program Again Ranked #1 in Philadelphia Region by U.S. News & World Report
Express News | Arcadia Biosciences Inc - Enters Agreement to Transfer Patents and Rights With a Third Party- SEC Filing
Arcadia Biosciences | 10-K: FY2024 Annual Report
Lake Street Maintains Arcadia Biosciences(RKDA.US) With Buy Rating, Maintains Target Price $12
Arcadia Biosciences (RKDA) Gets a Buy From Lake Street